First-line treatment of advanced non-small-cell lung cancer (NSCLC) with vinorelbine and cisplatin.

被引：0
|
作者：
Bobilev, D [1 ]
Ariad, S [1 ]
Geffen, DB [1 ]
Cohen, Y [1 ]
机构：
[1] Soroka Univ, Med Ctr, Beer Sheva, Israel
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
539P
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [31] Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)
    José Rodrigues Pereira
    Sandro J Martins
    Sueli M Nikaedo
    Flora K Ikari
    BMC Cancer, 4
  • [32] Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures:: a pilot study
    Herrero, CC
    Martínez, EN
    Jaime, AB
    LUNG CANCER, 2000, 27 (01) : 47 - 53
  • [33] Oxaliplatin in First-line Therapy for Advanced Non-Small-Cell Lung Cancer
    Raez, Luis E.
    Kobina, Svetlana
    Santos, Edgardo S.
    CLINICAL LUNG CANCER, 2010, 11 (01) : 18 - 24
  • [34] First-Line Chemotherapy Treatment of Advanced Non-Small-Cell Lung Cancer Does Cisplatin versus Carboplatin Make a Difference?
    Tiseo, Marcello
    Ardizzoni, Andrea
    Boni, Luca
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : E82 - E82
  • [35] First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial
    Wachters, FM
    van Putten, JWG
    Kramer, H
    Erjavec, Z
    Eppinga, P
    Strijbos, JH
    de Leede, GPJ
    Boezen, HM
    de Vries, EGE
    Groen, HJM
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1192 - 1199
  • [36] First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial
    F M Wachters
    J W G van Putten
    H Kramer
    Z Erjavec
    P Eppinga
    J H Strijbos
    G P J de Leede
    H M Boezen
    E G E de Vries
    H J M Groen
    British Journal of Cancer, 2003, 89 : 1192 - 1199
  • [37] Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary
    Provencio, M.
    Sanchez, A.
    Artal, A.
    Sanchez Torres, J. M.
    de Castro, J.
    Domine, M.
    Vinolas, N.
    Sanchez, A.
    Perez, F. J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (08): : 659 - 664
  • [38] Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary
    M. Provencio
    A. Sánchez
    A. Artal
    J. M. Sánchez Torres
    J. de Castro
    M. Dómine
    N. Viñolas
    A. Sánchez
    F. J. Pérez
    Clinical and Translational Oncology, 2013, 15 : 659 - 664
  • [39] Clinical experience with carboplatin (CBDCA) and oral vinorelbine (NVBO) in first-line advanced non-small cell lung cancer (NSCLC) treatment
    Garcia Adrian, S.
    Firvida, J.
    Marrupe, D.
    Salgado, M.
    Perez Lopez, E.
    Perez, F. J.
    Mendez, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Cisplatin (CDDP) plus vinorelbine (NVB) as first-line treatment for advanced non-small-cell lung cancer (NSCLC): Retrospective analysis to improve the patient's convenience on day 8 NVB administration
    Provencio, M.
    de las Penas, R.
    Cobo, M.
    Massuti, B.
    Artal, A.
    Munoz-Langa, J. M.
    Garcia-Gomez, R.
    Sanchez-Ruiz, A.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345